StemLifeLine

StemLifeLine was a biotechnology company that specialized in the derivation and banking of personalized human embryonic stem cell (hESC) lines. Founded in 2003 by Dr. Ana Krtolica and based in San Carlos, California, the company offered a unique service to individuals undergoing in vitro fertilization (IVF) to preserve stem cells from their excess embryos for potential future therapeutic use. This "biological insurance" model was designed to provide families with genetically matched cells for regenerative medicine and drug discovery applications. The company's platform involved extracting cells from early-stage embryos to create stable, cryopreserved cell lines. Despite its pioneering role in the personalized stem cell industry, the company faced significant ethical debate and eventually ceased its operations.